Apr 29, 2021
In this episode, VK Gadi, MD,
PhD, discusses his path to oncology, the
importance of positively disrupting the health care system and how
innovation can change the traditional model of health care.
- Intro :13
- About Gadi :29
- The interview 2:00
- What was your journey to where you are now? How did you get
- What led to the transition from the Fred Hutch Cancer Center to
the University of Illinois? 3:53
- How was it moving across the country in the middle of a global
- Do you have thoughts on what we need to do in health care to
disrupt the system and rebuild or recreate a better, more equitable
system in general and, specifically, in cancer care?
- Do you think that this pandemic is going to lead us in a path
where people will be more open to a new way of thinking?
- Do you think that coming out of this pandemic are there going
to be any tangible or major changes that you’ve seen in your own
practice or seen across the board that may continue to make access
or delivery of care better? 11:53
- How do you go about that process of figuring out how to
continue to lead equitably but also making sure you’re leading
- How do you guide women to keep their eyes open and continue to
evolve and grow while finding the right people to help them grow
and create those steeping stones to success?
- Cancel culture in medicine 28:36
- Dealing with institutions with a negative organizational
- Gadi’s one pearl of wisdom 36:39
- How to reach Gadi 37:37
VK Gadi, MD, PhD, is professor and director of
medical oncology in the department of medicine, and associate
director of translational oncology at UIC Cancer Center.
We’d love to hear from you! Send your comments/questions to Dr.
Jain at firstname.lastname@example.org.
Follow us on Twitter @HemOncToday @ShikhaJainMD. Dr. Gadi can
be reached by email at email@example.com and on Twitter @DrVKGadi.
Disclosures: Gadi reports research funding from
Agendia; intellectual property of Chimerocyte; consultant/speaker
for Hologix and he is founder of SEngine Precision Medicine. Jain
reports she is a paid freelance writer for Lippincott.